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Abstract
Background: Bradford, one of the most deprived cities in the United Kingdom, has a wide range of public
health problems associated with socioeconomic deprivation, including an infant mortality rate almost
double that for England and Wales. Infant mortality is highest for babies of Pakistani origin, who comprise
almost half the babies born in Bradford. The Born in Bradford cohort study aims to examine
environmental, psychological and genetic factors that impact on health and development perinatally, during
childhood and subsequent adult life, and those that influence their parents' health and wellbeing. This
protocol outlines methods for the recruitment phase of the study.
Methods: Most Bradford women attend for antenatal care and give birth at the Bradford Royal Infirmary,
which has approximately 5,800 births per year. Women are eligible for recruitment if they plan to give
birth here. Babies born from March 2007 are eligible to participate, recruitment is planned to continue
until 2010. Fathers of babies recruited are invited to participate.
Women are usually recruited when they attend for a routine oral glucose tolerance test at 26–28 weeks
gestation. Recruitment of babies is at birth. Fathers are recruited whenever possible during the antenatal
period, or soon after the birth. The aim is to recruit 10,000 women, their babies, and the babies' fathers.
At recruitment women have blood samples taken, are interviewed to complete a semi-structured
questionnaire, weighed, and have height, arm circumference and triceps skinfold measured. Umbilical cord
blood is collected at birth. Within two weeks of birth babies have their head, arm and abdominal
circumference measured, along with subscapular and triceps skinfold thickness. Fathers self-complete a
questionnaire at recruitment, have height and weight measured, and provide a saliva sample.
Participants are allocated a unique study number. NHS numbers will be used to facilitate record linkage
and access to routine data. A wide range of hospital and community sources is being accessed to provide
data for the women and children. Data are checked for accuracy and consistency.
Conclusion: Born in Bradford will increase understanding of the factors that contribute to health and
wellbeing, and identify factors that influence differences in them between people of Pakistani and European
origin.
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Bradford District, in West Yorkshire in the north of Eng-
land, with a population of approximately half a million
people, is one of the most deprived cities in the United
Kingdom. It has a wide-range of public health problems
that are associated with socioeconomic deprivation,
including a particularly high infant mortality rate.[1]
Twenty percent of Bradford city residents are of South
Asian origin, almost all being from the Mirpur region of
Pakistan. The population is younger than the national
average, and the city also has a higher than average birth
rate. Almost half the babies born in Bradford have parents
of Pakistani origin (50% white; 44% Pakistani; 4% Bang-
ladeshi; 2% other).[1] Between 1996 and 2003 infant
mortality in Bradford was 9.1 deaths per 1000 live births,
almost double that for England and Wales as a whole
(5.3/1000). Mortality was higher for babies of Pakistani-
origin (12.9/1000), than for those of European origin
(7.1/1000), and worse for first generation Pakistani immi-
grants but improved for second and subsequent genera-
tions of immigrants. These children also have higher
childhood morbidity than infants of European origin. [2-
4] The city is therefore an ideal setting for research to
explore the pathways linking socioeconomic deprivation
with ill-health and impaired development, and for explor-
ing differences between people of European and Pakistani
origin in their experience of health, wellbeing and social
capital.
The Born in Bradford cohort study will examine how
genetic, nutritional, environmental and social factors
impact on health and development during childhood,
and subsequently in adult life. It will also examine how
nutritional, environmental and social factors influence
the woman's subsequent health and wellbeing. The ulti-
mate aim will be to develop hypotheses, which can then
be evaluated and tested, for health and social interven-
tions to improve childhood and adult health.
This protocol outlines the study methods and design con-
siderations for the recruitment phase of this longitudinal
cohort study of babies born in Bradford, and their moth-
ers and fathers. It also presents the questionnaires and
other materials used for recruitment. It is anticipated that
protocols for each phase of follow up of participants in
the cohort will be developed. Study methods for recruit-
ment were initially developed during 2005–6. In late
2006 through to early 2007, feasibility of the recruitment
process, administration of the baseline questionnaire, and
record linkage to routine data were piloted and assessed.
This protocol therefore outlines the methods as agreed
following the assessment of feasibility. These methods
have been implemented for recruitment to the cohort
since mid-2007.
Study aims
The broad aims of the Born in Bradford cohort study are
to:
• describe and compare health and ill-health within a
largely bi-ethnic population
• identify modifiable causal pathways that promote well-
being, or contribute to ill-health
• develop a model for integrating research into routine
data systems within the National Health Service (NHS) in
England and Wales, and potentially health care systems in
other countries
• build and strengthen local research capacity
Prospective cohort studies are a resource for current and
future research, potentially for many decades and across
generations. Our aim is that the Born in Bradford cohort
study provides a robust and broad platform for existing
and future research questions. Below is a list of specific
research objectives agreed as of March 2008 by the Born
in Bradford Executive and Scientific Collaboration Group
(see end for membership of these groups).
1. To monitor maternal and child health, and to investi-
gate the association between genetic, obstetric, socioeco-
nomic, ethnic and lifestyle characteristics and risk factors,
and infant and childhood mortality and morbidity.
2. To determine the prevalence of congenital anomalies in
Bradford, and to describe their nature and association
with consanguinity and other risk factors.[5,6]
3. To compare birthweight between the offspring of South
Asian and European origin mothers born within Bradford,
and to determine whether the magnitude of any differ-
ences change with subsequent generations (comparing
1st, 2nd and 3rd) of migrant mothers. [7-9]
4. To examine the association between birth weight and
obstetric (including parity, maternal glucose tolerance,
weight gain during pregnancy and complications of preg-
nancy) and socioeconomic factors, and family and life-
style characteristics. Also, to explore the extent to which
any of these characteristics might explain differences in
birthweight between European and South Asian origin
families.[10,11]
5. To determine whether the fat-thin insulin resistant phe-
notype seen in adults and children of South Asian origin
is present at birth. That is, to determine whether, despite
their lower birth weight, South Asian origin babies are
more adipose (as indicated by cord leptin levels and sub-Page 2 of 13
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indicated by cord insulin and lipid levels) than European
origin babies.[12,13]
6. To examine the extent to which women's obesity,
weight gain during pregnancy, modifiable behaviours and
gestational diabetes mellitus contribute to insulin resist-
ance, diabetes, and obesity in their offspring during
infancy and early childhood, and to determine whether
any of these effects differ between South Asian and Euro-
pean origin ethnic groups. [14-16]
7. To investigate differences in health, and in social and
cultural environment and experiences, between people of
South Asian and European origin, and to explore how any
such differences might influence outcome at birth and
postnatal health for both the woman and child. [17-20]
8. To investigate if there are ethnic differences in renal
anthropometric indices and explore if there is an associa-
tion between birth weight and renal size. Also to deter-
mine which parental and pregnancy related factors might
explain such differences. [21-23]
9. To investigate the association between gestational dia-
betes mellitus and adverse obstetric outcomes.[24,25]
10. To examine the association of maternal vitamin D lev-
els with fasting and postload glucose levels and with
maternal blood pressure, and to examine the association
of maternal vitamin D levels with offspring birth size,
infant size, cord leptin, insulin and lipids, and future
markers of cardiovascular risk factors in infancy and child-
hood.[26,27]
11. To investigate the association between dietary expo-
sure to chemicals with carcinogenic and immunotoxic
properties, intermediate markers of cancer risk and
immune disorders. [28]
12. To investigate the relationship between occupational
factors, traffic-related air pollution and chlorination dis-
infection by-products in drinking water and intrauterine
growth restriction.[29,30]
13. To describe the growth and development of children
in a bi-ethnic cohort, and to explore the nutritional and
environmental factors that influence growth and develop-
ment during infancy and early childhood.[11,31]
14. To identify symptoms of emotional and physical dis-
tress in pregnancy, and explore the meanings given to
them by women of different cultural and ethnic back-
grounds. [32-34]
15. To describe the epidemiology of infant and early
childhood infections, and explore the hypothesis that
viral infections in early life influence the risk of later
immune-related diseases.[35,36]
Methods
Bradford is served by a single maternity unit, at the Brad-
ford Royal Infirmary (BRI), with approximately 5,800
deliveries per year. Almost all women resident in Bradford
book, and give birth, in the maternity unit. Only about 10
women per year have a home birth, and a small number
are transferred in utero to another unit, or deliver else-
where for other reasons. The eligible population for this
cohort study is all pregnant women who plan to, and then
do, give birth at the BRI over the period of recruitment,
their subsequent live born offspring, and their partners.
Over time 'new' parental figures for the offspring will
become part of the eligible study population.
Eligibility and exclusion criteria
For the women
All women planning to give birth at the BRI will be eligi-
ble for recruitment, regardless of parity. Women who have
been recruited to the study will remain in the study, if they
wish to, regardless of whether the baby is liveborn or still-
born, and irrespective of whether the child is adopted or
fostered.
The only exclusion criterion for recruitment of a woman
will be if she plans to move away from Bradford before the
birth. As recruitment to the study is anticipated to take
place over 36 months, some women will have more than
one pregnancy during this period. The woman, and her
subsequent offspring, will be eligible for each pregnancy.
For the children
All babies born to women who have agreed to participate
in the cohort study will be eligible for recruitment. If the
woman does not want to participate in the cohort herself,
she can still agree that her child participate.
For stillborn babies recruitment to the cohort will be at
birth, as it is for liveborn babies. For these babies there
would, of course, be no further participation.
For the fathers
Fathers of babies who have been recruited to the cohort
will be invited to participate when the mother attends for
her oral glucose tolerance test, at another convenient time
during pregnancy, or soon after the birth. The normal pro-
cedure will be to invite the woman's current partner to
participate, regardless of whether or not he is the baby's
genetic father. If there is uncertainty about who to
approach, the woman will be asked who should bePage 3 of 13
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the future, he will also be invited to participate.
For adoptive parents and foster carers
Adoptive parents and foster carers will be invited to partic-
ipate in the study, if appropriate.
Recruitment
The study aims to recruit 10,000 babies. Recruitment
began in March 2007 and is planned to continue until
2010. Approximately half the babies born in Bradford
have parents of South Asian origin, primarily from Paki-
stan. People from ethnic minorities are as likely as those
from majority populations to agree to participate in
research, provided they receive an appropriate invitation
in a language they understand.[37,38] We will do our
utmost to ensure that the study is appropriately explained
and that language is not a barrier to participation. We
therefore estimate 80% uptake for the women and chil-
dren, with 75% retention over five years. Uptake and
retention for the partners is likely to be considerably
lower.
Ethnicity
Mothers are asked to self report their own and the baby's
father's ethnicity, where they were born and how long
they have lived in this country. They are also asked to state
the ethnicity of theirs and the baby's father's parents and
grandparents. If fathers are recruited into the study they
are requested to self report to which ethnic group they
belong, where they were born (UK, Pakistan or other) and
how long they have lived in this country.
Information about the study has been widely dissemi-
nated throughout the community, in appropriate lan-
guages, using a range of media such as local newspapers,
video, radio and TV and the internet through a project
website. Links have been developed with community
organisations, including the primary health care trust,
mosques, other faith groups, schools and colleges. Writ-
ten information about the study has been made widely
available, so that families are aware of the study before
they attend for antenatal care.
Women are given the Patient Information leaflet (see
Additional file 1) at their first antenatal appointment.
They have an opportunity to ask questions and discuss the
project at subsequent antenatal visits. This leaflet is also
available to women when they come to the BRI for ante-
natal appointments and for ultrasound scans. Muslim
women are offered an additional leaflet that discusses
research and the Born in Bradford project from an Islamic
perspective (see Additional file 2).
Most people of Pakistani origin living in Bradford speak
either Urdu or Mirpuri. The Patient Information leaflet
has therefore been translated into Urdu. As Mirpuri does
not have a written script, the patient information was
transliterated (see 3.5 below). The other non-English
speaking communities represent less than 3% of deliver-
ies, and are largely from Eastern European countries such
as Poland, Slovakia and the Czech Republic. These
women are recruited with the aid of interpreters, when-
ever possible, and a summary leaflet outlining the recruit-
ment process and inviting participation has been
translated into Polish, Czech and Slovakian (see Addi-
tional file 3).
Sample size
Comparable cohorts to estimate feasibility of recruitment
are scarce. ALSPAC is a slightly larger cohort study which
recruited more than 10 years ago. Women were recruited
earlier in pregnancy than proposed for our study, and less
than 10% were 'non-white'. Recruitment to ALSPAC was
estimated to be 80–90% of eligible women, and 551 were
excluded because they miscarried before 20 weeks gesta-
tion. Of the 13990 women who delivered after 20 weeks,
69 (0.5%) were lost to follow up before delivery. Among
the 14130 babies born after 20 weeks, 68 were stillborn
and 53 were neonatal deaths. Response rates to postal
questionnaires were around 80% at five years, for both
women and children. For the fathers they were around
50%.
Although our study will have a much larger proportion of
women and partners from ethnic minorities, there is a
growing body of evidence that people from ethnic minor-
ities are as likely as those from majority populations to
agree to participate in research. The main barriers to par-
ticipation are that an invitation is not offered, or that it is
in a language the person does not understand. Once peo-
ple are invited to participate in a language they under-
stand, the likelihood they will accept does not seem to be
related to their ethnic group. The challenge for the Born in
Bradford study will therefore be to ensure that language is
not a barrier to full participation. We estimate 80% uptake
for the women and children, with 75% retention over five
years. Uptake and retention for the partners is likely to be
lower, at 50% uptake and 70% retention.
Recruitment of the women
All women booked for delivery at the BRI are offered an
oral glucose tolerance test (oral GTT) at 26 to 28 weeks
gestation. When they attend for the oral GTT, women are
invited to participate in the Born in Bradford cohort. If
they agree, they are asked to first give verbal consent to
having a project blood sample (total 13 ml) for inclusion
in the Biobank, taken at the same time as the fasting oral
GTT sample. Once these blood samples have been taken,Page 4 of 13
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with a member of the project team, and to decide if they
wish to sign a consent form (see Additional file 4). Once
this consent form has been signed, women are invited to
complete the baseline questionnaire with a trained project
worker (see Additional file 5), and to have anthropomet-
ric measurements taken. Most of the questionnaire is
completed by interview with the project worker, with the
final section completed by the woman herself (see
below).
After having blood taken, if the woman decides she does
not wish to participate she can request that her samples be
destroyed. If verbal consent to take extra blood is
declined, the woman can still be recruited to the study.
Similarly, if a woman has already had the fasting blood
sample taken for her oral GTT before she is approached to
ask about participation in the cohort, she can nevertheless
be invited to participate.
Overall, 80% of women who are booked to give birth at
the BRI attend for the oral GTT. Women who do not
attend or who, for operational reasons, are not
approached during their visit for the oral GTT, are invited
to participate at other times. For example, women with
pre-existing diabetes are invited to participate when they
are at 28 weeks gestation, or above, during a clinic
appointment, or at another appropriate opportunity.
Women who have not been offered participation are also
invited to participate when they attend the pre-assessment
clinic. If a woman has been invited to participate and
refused, she will not be approached again.
Recruitment of the babies
Women who sign the consent form thereby give consent
for their babies to be included in the study. These babies
are then recruited into the cohort at birth, regardless of
whether they are liveborn or stillborn.
Recruitment of the fathers
Fathers who accompany women when they attend for the
oral GTT are also invited to participate. If they agree to
take part and sign the consent form (see Additional file 6),
they have height and weight recorded, and are asked to
complete a self administered questionnaire (see Addi-
tional file 7) and to provide a saliva sample. If the father
was not approached during the oral GTT visit, he is invited
to participate if he accompanies his partner during other
hospital visits, or after the birth.
Inclusion of women and fathers following a stillbirth, neonatal death 
or infant death
Following a stillbirth, neonatal death, or infant death the
women and fathers will remain in the cohort. Future fol-
low up will ensure that any contact with the family is sym-
pathetic and appropriate.
Withdrawal of consent
A woman may withdraw from the study, or withdraw her
child, at any time. Once a request for withdrawal has been
received a letter is sent to the mother thanking her for her
participation and confirming if she wishes any data col-
lected for her and/or her child up to that point in time
(biological, questionnaire or routinely collected informa-
tion) to be destroyed. Similarly, a father may withdraw
from the study at any time. They will not be contacted
again, and no further data will be collected for her and/or
her child. Data and biological samples that have already
been collected for a participant who later withdraws will
be retained for analysis, unless consent for storage and
analysis has also been withdrawn, in which case they will
be destroyed.
Unique study identifier
Each woman is allocated a unique study number at
recruitment. This number will be used to identify and
track her anonymised data throughout the study. It is vital
for linking information across the study, and for ensuring
confidentiality. Similarly, the woman's child and her part-
ner are allocated a unique identifier, but one that is linked
to hers. Hence, each family unit will be identified and
linked, whilst maintaining confidentiality. The system for
allocating study identifiers also allows a new partner to be
added to the family unit, and identifies second and subse-
quent pregnancies during which the woman is recruited to
the cohort.
In addition, NHS numbers are collected for all study par-
ticipants. These will be used to facilitate record linkage.
Demographic details collected when the consent form is
signed are validated via the National Strategic Tracing
Service (NSTS), soon to be replaced by the Patient Demo-
graphic Service (PDS), to check the NHS number and
identify the general practitioner.
Translation and transliteration of trial materials
Most people in Bradford who describe themselves as Paki-
stani come from families who migrated from the Mirpur
region of north eastern Pakistan. Although there are some
smaller Pakistani communities, the vast majority of peo-
ple are able to understand Urdu or Mirpuri. Literacy in
these languages is not universal, however. A further com-
plication is that Mirpuri does not have a written form in
use; it is sometimes regarded as a dialect of Punjabi rather
than a separate language. To reduce the need for transla-
tors, and to facilitate consistent and accurate data collec-
tion, the baseline questionnaire has been transliterated
into Urdu and Mirpuri using a standardised process (see
Additional file 8). Bilingual project workers who adminis-Page 5 of 13
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literated versions.
Routine data to be collected at recruitment, and up to the 
time of the birth
The aim is to maximise the utility of routinely collected
data within the NHS systems, hence potentially providing
comprehensive and cost effective data collection. A wide
range of sources will be accessed to provide baseline data
for the women and children at recruitment; for example
haematology and biochemistry results, ultrasound data,
and general practice data.
For the mother
Information about the women recorded as part of routine
clinical care at booking and throughout pregnancy and at
delivery will be obtained from hospital information sys-
tems (see Additional file 9). A new maternity electronic
record (eClipse) is being installed at the BRI; designed to
be completed by the care givers and used as the primary
clinical notes from booking to postnatal discharge. The
aim is that this will be a 'paper light' system, with the
advantage of clinical data being routinely collected in
electronic format, and therefore readily available for clin-
ical care whenever needed. An additional advantage is
that, with appropriate ethics approval and consent, it can
also be accessed for research purposes. While the transfer
from traditional records to eClipse is taking place, data
that are not available electronically are being manually
extracted from the paper records.
For the baby
Information about the baby at birth is also being collected
within eClipse as part of routine care, and is therefore
available from these electronic records.
For the father
No routinely collected data will be accessed either at
recruitment or around the time of the birth for the father.
Project data to be collected at recruitment, and up to the 
time of the birth
As routine data may not provide comprehensive and reli-
able information about issues such as ethnicity, culture,
well being, lifestyle, and mental state, supplementary data
for the women and fathers will be collected using semi
structured questionnaires (see Additional files 5 and 7).
All women and fathers will be offered the opportunity to
complete these questionnaires. However, if the question-
naire is not completed, for whatever reason, they can still
participate in the study if they wish.
For the women
Women will be weighed and have height, arm circumfer-
ence and triceps skinfold measured at recruitment. The
baseline questionnaire developed for this study (see Addi-
tional file 5) will be administered by a trained project
worker at recruitment, regardless of whether that occurs
during the visit for the oral GTT or at another time. The
questionnaire is designed to be completed as part of a
semi-structured interview, with a final section containing
the General Health Questionnaire 28 (GHQ 28) and exer-
cise questions being self completed. The questionnaire
includes already existing and previously validated ques-
tionnaires where ever possible, plus additional questions
developed by the Born in Bradford project team for topics
on which appropriate existing questions could not be
found. Its content reflects baseline data needs defined by
the broad aims and specific objectives of Born in Bradford
(see above). The source for each question in the question-
naire is listed in Additional file 10.
The project worker administering the baseline question-
naire will remain with the woman while she completes
the self-completed section, and will be willing to answer
questions. This same project worker will check the self-
completed section has been fully completed before the
woman leaves. If the woman indicates either by her
answers to the final section of the GHQ 28, or in conver-
sation, that she has suicidal thoughts or feelings, there will
be a standard procedure for informing the woman of
counselling and other support that is available to her.
In addition to the baseline questionnaire, a dietary ques-
tionnaire will be given to all women recruited to the study
while they are waiting for their oral GTT. They will be
invited to complete this questionnaire and return it to a
member of the project team before they leave. This ques-
tionnaire will be self-explanatory, and will be completed
without the assistance of the project workers.
For the babies
At, or soon after, birth the babies will have their head, arm
and abdominal circumference measured, along with sub-
scapular and triceps skinfold thickness.
For the fathers
The fathers' baseline questionnaire (see Additional file 7)
is also administered at recruitment. This questionnaire is
self completed. Fathers have their height and weight
measured.
Biological samples to be collected and stored at 
recruitment
As outlined above, assay results from biological samples
collected and analysed within the context of routine care
for the women and babies will be available for those who
have consented to recruitment.Page 6 of 13
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Women who are recruited at their oral GTT have an addi-
tional fasting blood sample taken for the project. This is
used to measure insulin, glucose, and lipid profile, with
13 mls then prepared for storage at -80°C: serum, whole
blood, plasma, buffy coat and red blood cells. A single
void urine sample of approximately 50 ml will be col-
lected into sterile specimen containers, and stored at -
80°C in the Biobank.
For the babies
At birth, umbilical cord blood will be collected for the
Biobank using the Vacutainer system The following sam-
ples will be stored at -80°C: serum, whole blood, plasma,
buffy coat and red blood cells.
For the fathers
Fathers will be asked to provide a single saliva sample at a
convenient time (such as when accompanying their part-
ner to the oral GTT), for storage at room temperature in an
Oragene® (DNA Genotek, Ottawa, Ontario, Canada) spec-
imen container. This will be used as a source of genomic
DNA.
Data quality and data management
A range of strategies will be utilised to maximize the qual-
ity of data collection. This will include validation checks
for consistency and completeness of routinely collected
data, training of project workers in administration of the
questionnaires, and training of clinical and project staff in
measurement of specific indices.
Training and quality assessment of project workers in administration 
of the women's questionnaire
All project workers who recruit to the study and adminis-
ter the baseline questionnaire have initial training in how
to explain the study, how to take consent and how to
administer the questionnaire using a range of strategies,
such as formal training sessions, practical demonstrations
and role play. A Born in Bradford training manual is used
to ensure standardization of instructions and consistency
of training standards for project workers throughout the
life of the project. Once they begin recruitment, each
project worker has a random sample (5%) of interviews
observed by an independent observer on a quarterly basis.
A set of interviewer notes is also provided to help stand-
ardise explanation of specific issues, and to eliminate
ambiguity (see Additional file 11).
Training and quality assessment for anthropometric measurements
Everyone who takes anthropometric measurements,
which includes both project workers and clinicians, is
trained in the appropriate technique. Training includes
how to check, calibrate and maintain the necessary equip-
ment.
The Technical Error of Measurement (TEM) is used to
assess reliability of the anthropometric measurements.
TEM is calculated from the data produced by a test-retest
reliability study (see Additional file 12). This requires the
measurer to assess the same infant twice (to assess intra-
observer reliability) or two or more observers to assess the
same infant (to assess inter-observer reliability). Until
there are sufficient data to assess reliability within this
study, the acceptable ranges of difference between two
measurements on the same person have been agreed (see
Additional file 13).
Data warehouse
All study data will be linked using NHS numbers and the
unique study identifier, and stored in a data warehouse.
This includes data from the clinical analysis of blood sam-
ples, data from the baseline questionnaires, and routine
clinical data (Figure 1). Data linkage, quality control, and
maintenance of the data warehouse are the responsibility
of Bradford and Airedale Teaching Primary Care Trust, on
behalf of Bradford Hospitals NHS Foundation Trust.
Data consistency
If a data item is available from more than one source, an
agreed process is used to validate the data and create a sin-
gle field containing the most reliable information. For
example, if ethnicity is collected from four sources, the
most common response would be used.
Where similar data are collected from more than one
source these are clearly documented. Information will be
provided to users of the data to enable them to choose the
field most appropriate to their requirements, or to con-
sider combining information from more than one field
when feasible or appropriate. All processes for data man-
agement and quality control are clearly documented and
agreed by the Data Management Group.
Data linkage
NHS numbers will be used to enable regular agreed
extracts of routinely collected data. Some systems, such as
those for maternity, child health and primary care, may
already have Born in Bradford study participants identi-
fied within them. Nevertheless, these will be regularly
cross-checked before data extraction to ensure any
changes in consent have been taken into account. Data
obtained in this way will be cross checked for consistency,
plausibility, and completeness. Further checks will vali-
date data across the different sources. Discrepancies and
inaccuracies will be checked and investigated.
Systems for data linkage to education and social services
records are being developed.Page 7 of 13
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A number of principles have been agreed with respect to
storage of the biological samples. First, samples should be
processed in such a way as to enable the widest possible
range of analytical tests to be conducted. This is in recog-
nition of the fact that it is not possible to predict from the
outset the scope of specific analyses. Second, the protocol
seeks a balance between the ideal intensity of sampling for
scientific purposes and the practical and logistic setting in
which the work is conducted. Third, samples are to be
processed in a timely fashion and there should be an
avoidance of freeze-thaw cycles. Fourth, cataloguing and
storage of samples will be subject to a secure and robust
inventory system. Fifth, best practice will be followed to
maintain the highest standard in clinical and research
governance, including fulfilling our obligations and
responsibilities laid down in the ethical and human tissue
authority legislation.
Sources of data from the Born in Bradford Data WarehouseFigur  1
Sources of data from the Born in Bradford Data Warehouse.
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procedures detailed above, the Biobank has a system for
recording the exact location of each sample and its storage
conditions. All samples are collected and processed fol-
lowing agreed Standard Operating Procedures (SOPs). All
deviations from these SOPs, such as temperature changes
or freeze/thaw episodes, and equipment failures, are
recorded. Review of all storage equipment will be done
annually. For each specimen the time from collection to
storage is recorded. All aliquots and samples have a
unique code to allow sample tracking. Consent for sam-
ples to be stored, and indeed where consent has been
revoked, is tracked so that if consent is withdrawn samples
can be destroyed in a timely manor, and this procedure
recorded in the study database. A procedure will be put in
place for disposing of samples when consent is with-
drawn, or when a sample has not been collected in an
acceptable time-frame.
Research governance and confidentiality
Research Governance approval has been secured from
Bradford Teaching Hospitals NHS Foundation Trust and
the Bradford and Airedale Teaching Primary Care Trust.
Data collection will comply with the Data Protection Act
1998. Files containing personal identifiers (such as name,
address, telephone number) will be stored in locked cab-
inets or rooms within the project co-ordinating centre,
and separate from the data used for analysis. Researchers
who are not part of the project co-ordinating centre
(including those on the Executive and Scientific Collabo-
rators groups) will not have access to personal identifiers.
Back up copies will be subject to the same degree of data
security. Data will be released for analysis using the
unique study identifier only, hence protecting the identity
of individual participants.
Ethics approval and indemnity
The protocol for recruitment and collection of baseline
data and biological sample for the cohort has been
approved by the Bradford Research Ethics Committee. All
participants will be asked to sign a consent form (see
Additional files 4 and 6), which includes permission to
use genetic data obtained from biological samples. Stand-
ard procedures for the protection of confidential individ-
ual information will be applied, as outlined above.
Samples will be collected and stored in accordance with
the Human Tissue Act 2004, including ensuring appropri-
ate licences are in place.
Analysis plan
Throughout the initial data collection period regular com-
parisons will be made between women recruited to the
study, and those eligible but not recruited, using routinely
available data for women who book to give birth at the
BRI. These comparisons will be used to target recruitment
for particular groups, as appropriate. For example an ini-
tial analysis of the first 500 women recruited to the cohort
demonstrates that our cohort is highly representative of
the eligible population with one exception: fewer very
young (under 18 years) pregnant women were recruited
compared to those in the eligible population. As a result,
community midwives and ante natal support services
working with this age group have been asked to discuss
the study with young pregnant women. Representative-
ness of this cohort will continue to be monitored through-
out data collection, with appropriate strategies developed
to rebalance recruitment should any group be found to be
under-represented. A final report on characteristics and
demographics for the whole cohort will be produced at
the end of recruitment.
For each project planning to use the Born in Bradford
cohort, an analysis plan will be developed before com-
mencing data analysis.
Project management
Successful conduct of this study will require considerable
input from a wide range of people locally within the Brad-
ford Teaching Hospitals NHS Foundation Trust, Univer-
sity of Bradford, Bradford and Airedale Teaching Primary
Care Trust, University of Leeds and academic partners
from collaborating institutions: University of Bristol, Uni-
versity of Edinburgh, University of Loughborough, Lon-
don School of Hygiene and Tropical Medicine, Imperial
College London.
Executive Group
This group has responsibility for oversight of the project,
including: monitoring project progress against mile-
stones, oversight of the study conduct, strategic planning,
planning grant applications, co-ordinating nested study
applications, oversight of the budget, ensuring the project
meets the requirements of Research Governance and data
protection. The Executive Group are also responsible for
producing quarterly reports for the Trust Board.
Project Management Group
This group meets every one to two months and is respon-
sible for day to day implementation of the project, includ-
ing co-ordination of clinical and research staff
contributing to the project, development of the support-
ing IT systems, training and awareness of clinical and
research staff, monitoring of monthly recruitment, and
monitoring of collection, analysis and storage of biologi-
cal samples.
Scientific Collaboration Group
This group meets quarterly and provides academic review
and support for the project. Specific roles include: contrib-
uting to the design and methods of the project, collabora-Page 9 of 13
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dissemination of research results, providing strategic sci-
entific direction.
Advocacy and Scrutiny Committee
This committee acts as an independent body and has a
broad remit to review and comment on the overall direc-
tion and intentions of Born in Bradford as well as specific
areas, including new questions; new measures including
biological samples; nested studies; protocol based pro-
spective measures and participant information. Its struc-
ture, membership and operating procedures are in
Additional file 14. The group reports to the Trust Board via
the Executive Group.
Intellectual property and principles of collaboration
Born in Bradford is a platform study that aims to increase
our understanding about how we can improve health and
well-being within Bradford, and to contribute to our
understanding of the causes of disease and promotion of
health more widely. It also aims to increase research
capacity in Bradford by offering opportunities for local
researchers, and by attracting the involvement of high cal-
ibre external research partners. Implementation of the
study is dependent on the commitment and contributions
of a wide variety of health professionals and researchers,
including midwives, obstetricians, paediatricians, labora-
tory staff, health visitors, health service managers and gen-
eral practitioners. But it also depends on active
participation by the parents and children recruited to the
study, and the many community groups and individuals
who support that involvement. The project policy on gov-
ernance, intellectual property and authorship is in Addi-
tional file 15.
Born in Bradford is therefore dependent on the input and
contributions of a large number of stakeholders. This plu-
rality is a strength of the study, but may also lead to con-
fusion over ownership. All research outputs from the
study should clearly acknowledge the contribution from
the Bradford community. The cohort study has been set
up to attempt genuine public engagement and the Born in
Bradford cohort should therefore be seen as active con-
tributors rather than just passive participants.
Proposals for collaboration or for projects that use data
from the cohort from external groups are welcome, but
until recruitment is completed there cannot be any guar-
antees about data availability. Once all data have been
collected and validity and consistency checks completed,
the study will be promoted more widely. For example, by
convening a preliminary meeting for potential external
researchers at which the cohort will be described, along
with presentation of some initial descriptive data. At that
stage proposals for future research collaboration will be
actively encouraged.
Researchers with proposals to use data from the cohort
should in the first instance complete an outline pro forma
available on the Born in Bradford website.[39] These will
be reviewed by the Executive group. Those agreed by the
Executive Group will be discussed with the Scientific Col-
laborators Group. They will also be made known to the
Advocacy and Scrutiny Committee who will be invited to
comment. The principles for agreeing a proposal and
releasing data from the study to external researchers are
that the proposal (a) meets the broad study aims; (b) out-
lines research that has not already been completed, is in
progress or has been agreed with another group of
researchers; (c) is feasible, and realistically budgeted, in
the Born in Bradford cohort; (d) will not bring the study
into disrepute or cause offence to the participants. Where
appropriate, collaboration with Bradford researchers will
be particularly encouraged, in order to build local
research capacity.
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Additional material
Additional file 1
Parents' information sheet. Information leaflet sent out to families before 
they are approached to take part in Born in Bradford.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2458-8-327-S1.pdf]
Additional file 2
Islamic Perspective Leaflet. Leaflet offered to Muslim women outlining the 
aims of the project from an Islamic perspective.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2458-8-327-S2.pdf]
Additional file 3
Polish, Slovakian and Czech Leaflet. Summary leaflet handed out to 
Polish, Slovakian and Czech mothers explaining the study and offering the 
help of an interpreter if they wish to take part.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2458-8-327-S3.doc]Page 10 of 13
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Guidance and conditions for collaborators on the Born in Bradford pro-
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